Baxter International | BAX - Net Income


Baxter International reported $-15M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Fresenius EUR 361M 17M Dec/2025
Globus Medical USD 140.59M 21.63M Dec/2025
Halozyme Therapeutics USD 150.05M 291.64M Mar/2026
ICU Medical USD -15.73M 12.34M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
J&J USD 5.53B 299M Jun/2026
Laboratory Of America USD 277.8M 113.1M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Merit Medical Systems USD 41M 2.99M Mar/2026
Quest Diagnostics USD 251M 6M Mar/2026
Smith & Nephew USD 293M 79M Dec/2025
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026